ATE468390T1 - System und verfahren zur produktion von antikörpern in der pflanzenzellkultur - Google Patents

System und verfahren zur produktion von antikörpern in der pflanzenzellkultur

Info

Publication number
ATE468390T1
ATE468390T1 AT05796809T AT05796809T ATE468390T1 AT E468390 T1 ATE468390 T1 AT E468390T1 AT 05796809 T AT05796809 T AT 05796809T AT 05796809 T AT05796809 T AT 05796809T AT E468390 T1 ATE468390 T1 AT E468390T1
Authority
AT
Austria
Prior art keywords
cell culture
plant cell
producing antibodies
antibodies
production
Prior art date
Application number
AT05796809T
Other languages
English (en)
Inventor
Yoseph Shaaltiel
Sharon Hashmueli
Daniel Bartfeld
Gideon Baum
Tal Ratz
Einat Mizrachi
Yehava Forester
Original Assignee
Protalix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protalix Ltd filed Critical Protalix Ltd
Application granted granted Critical
Publication of ATE468390T1 publication Critical patent/ATE468390T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13—Immunoglobulins specific features characterized by their source of isolation or production isolated from plants
AT05796809T 2004-10-13 2005-10-11 System und verfahren zur produktion von antikörpern in der pflanzenzellkultur ATE468390T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61764604P 2004-10-13 2004-10-13
PCT/IL2005/001075 WO2006040764A2 (en) 2004-10-13 2005-10-11 System and method for production of antibodies in plant cell culture

Publications (1)

Publication Number Publication Date
ATE468390T1 true ATE468390T1 (de) 2010-06-15

Family

ID=35462268

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05796809T ATE468390T1 (de) 2004-10-13 2005-10-11 System und verfahren zur produktion von antikörpern in der pflanzenzellkultur

Country Status (12)

Country Link
US (1) US8119406B2 (de)
EP (1) EP1799813B1 (de)
JP (1) JP2008515454A (de)
KR (1) KR20070085291A (de)
AT (1) ATE468390T1 (de)
AU (1) AU2005293147A1 (de)
CA (1) CA2583691A1 (de)
DE (1) DE602005021379D1 (de)
IL (1) IL182517A (de)
MX (1) MX2007004414A (de)
WO (1) WO2006040764A2 (de)
ZA (1) ZA200703124B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
US7951557B2 (en) 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US20100196345A1 (en) * 2003-04-27 2010-08-05 Protalix Production of high mannose proteins in plant culture
KR20070085291A (ko) 2004-10-13 2007-08-27 프로탈릭스 리미티드 식물 세포 배양에서 항체를 생산하는 시스템 및 방법
WO2008096250A1 (en) * 2007-02-09 2008-08-14 Centre National De La Recherche Scientifique - Cnrs Expression of polypeptides from the nuclear genome of ostreococcus sp
JP2010525833A (ja) 2007-05-07 2010-07-29 プロタリクス リミテッド 大規模な使い捨て型バイオリアクター
US9051359B2 (en) 2009-03-30 2015-06-09 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
PT3482767T (pt) 2009-08-28 2021-12-29 Icahn School Med Mount Sinai Terapia de substituição enzimática com escaladas de dose para tratamento de deficência da esfingomielinase ácida
KR20130075732A (ko) 2010-03-30 2013-07-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 백신 및 이의 용도
ES2953393T3 (es) 2011-09-20 2023-11-10 Icahn School Med Mount Sinai Vacunas contra el virus de la influenza y sus usos
BR112015014482A2 (pt) 2012-12-18 2017-11-21 Icahn School Med Mount Sinai vacinas para vírus influenza e seus usos
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
WO2015105551A1 (en) 2014-01-09 2015-07-16 Kentucky Bioprocessing, Inc. Method of purifying monoclonal antibodies
GB201411802D0 (en) 2014-07-02 2014-08-13 Univ Bradford Effervescent compositions
US9340604B1 (en) 2014-10-29 2016-05-17 Aridis Pharmaceuticals, Inc. Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)
WO2016118937A1 (en) 2015-01-23 2016-07-28 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
EP3471767A4 (de) 2016-06-15 2020-01-15 Icahn School of Medicine at Mount Sinai Influenzavirus-hämagglutinin-proteine und verwendungen davon
EP3550028A4 (de) 2016-11-30 2020-09-02 Kirin Holdings Kabushiki Kaisha Verfahren zur herstellung von nützlichen proteinen mithilfe einer pflanze
EP3606555A4 (de) 2017-04-07 2021-08-04 Icahn School of Medicine at Mount Sinai Neuraminidase-antikörper gegen influenza-b-virus und verwendungen davon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080560A (en) 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
AR020090A1 (es) * 1998-06-15 2002-04-10 John Innes Ct Celula vegetal monocotiledonea o semilla de ella,planta o parte de una planta, metodo para hacer una celula vegetal monocotiledonea, metodo para hacer unaplanta, uso de una construccion de expresion para producir una celula de planta o semilla monocotiledonea, y uso de una construccion de expresion
AU6021699A (en) 1998-09-01 2000-03-21 Penn State Research Foundation Method and apparatus for aseptic growth or processing of biomass
US6528063B2 (en) 1999-01-04 2003-03-04 Rahan Meristem Recombinant vaccines against IBDV
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
WO2002101006A2 (en) * 2001-06-08 2002-12-19 Icon Genetics, Inc. Production of proteins in plants
WO2003013598A2 (en) 2001-08-09 2003-02-20 Lam Dominic M K Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases
AR042145A1 (es) 2002-11-27 2005-06-08 Dow Agrociences Llc Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
EP1431394B1 (de) 2002-12-20 2006-08-02 greenovation Biotech GmbH Verfahren zur Herstellung von glykosylierten Proteinen in Bryophyten Zellen
KR20070085291A (ko) 2004-10-13 2007-08-27 프로탈릭스 리미티드 식물 세포 배양에서 항체를 생산하는 시스템 및 방법

Also Published As

Publication number Publication date
ZA200703124B (en) 2008-08-27
JP2008515454A (ja) 2008-05-15
EP1799813A2 (de) 2007-06-27
WO2006040764A2 (en) 2006-04-20
US20090082548A1 (en) 2009-03-26
AU2005293147A1 (en) 2006-04-20
US8119406B2 (en) 2012-02-21
CA2583691A1 (en) 2006-04-20
DE602005021379D1 (de) 2010-07-01
WO2006040764A3 (en) 2006-07-06
IL182517A (en) 2012-06-28
MX2007004414A (es) 2007-09-25
IL182517A0 (en) 2007-09-20
KR20070085291A (ko) 2007-08-27
EP1799813B1 (de) 2010-05-19

Similar Documents

Publication Publication Date Title
ATE468390T1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
DE602004025805D1 (de) Verfahren zur herstellung von antikörpern
ATE474910T1 (de) L-glutaminsäure produzierender mikroorganismus sowie verfahren zur produktion von l- glutaminsäure
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
DK1428878T3 (da) Fremgangsmåde til produktion og oprensning af erythropoietin
EA201390082A1 (ru) Способ получения рекомбинантного adamts13 в культуре клеток
DK1851815T3 (da) Fremgangsmåde til fremstilling af en brændselscellekatode
TW200741000A (en) Method of producing lymphocytes
MX2008014692A (es) Metodo de cultivo para obtener una poblacion clonal de celulas b especificas de antigeno.
MX2020001944A (es) Poblaciones de celula madre de la placenta.
EA200800996A1 (ru) Способ получения т-клеточной популяции
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
SG10201803982TA (en) Antibodies and processes for preparing the same
ATE469917T2 (de) Verfahren zur gewinnung von antikörpern
BR112015022529A2 (pt) meios de cultura de células e processos de produção de anticorpo
WO2010020876A3 (en) Cell culture method to form aggregates
ATE336567T1 (de) Zellkulturmedium
PL439807A1 (pl) Sposoby oczyszczania przeciwciał i ich kompozycje
DK1797174T3 (da) Fremgangsmåde til fremstilling af virusmateriale
ATE374755T1 (de) Verfahren zur herstellung von 1,3,5- triazincarbamaten und -harnstoffen
EP1739167A4 (de) Verfahren zur virusproduktion
DE602006010934D1 (de) Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika
MX2009007790A (es) Mejora del crecimiento celular.
ATE346865T1 (de) Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp
DE602004023238D1 (de) Methoden zur Kultivierung von Antigen presentierenden Immunzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties